IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
IASLC Atlas of ALK and ROS1 Testing in Lung Cancer
September 21, 2017 | Online


These live webinars are intended to help pathologists, scientists and physicians better understand the background, protocol and interpretation of results of ALK and ROS1 testing for NSCLC patients. This webinar will: 

  • Introduce clinicians to the reference Atlas of Alk and ROS1 testing
  • Provide clinicians and scientists with a clear understanding of the background, testing protocols and interpretation of results of ALK and RPOS1 testing.
  • Identify and review the use of FISH (Fluoroescence In Situ Hybridization) and IHC (ImmunoHistoChemistry) to detect ALK.

Prof. Keith Kerr, 

Department of Pathology
Aberdeen University Medical School
Aberdeen Royal Infirmary
Aberdeen, UK


Ming-Sound Tsao, MD, FRCPC
Senior Scientist
Princess Margaret Cancer Center\Professor of
Laboratory Medicine and Pathology
M. Qasim Choski Chair in Lung Cancer Translational Research

University of Toronto, Canada